These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Dimerization of the Trk receptors in the plasma membrane: effects of their cognate ligands. Ahmed F; Hristova K Biochem J; 2018 Nov; 475(22):3669-3685. PubMed ID: 30366959 [TBL] [Abstract][Full Text] [Related]
26. NTRK fusion-positive cancers and TRK inhibitor therapy. Cocco E; Scaltriti M; Drilon A Nat Rev Clin Oncol; 2018 Dec; 15(12):731-747. PubMed ID: 30333516 [TBL] [Abstract][Full Text] [Related]
27. Discovery of Entrectinib: A New 3-Aminoindazole As a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor. Menichincheri M; Ardini E; Magnaghi P; Avanzi N; Banfi P; Bossi R; Buffa L; Canevari G; Ceriani L; Colombo M; Corti L; Donati D; Fasolini M; Felder E; Fiorelli C; Fiorentini F; Galvani A; Isacchi A; Borgia AL; Marchionni C; Nesi M; Orrenius C; Panzeri A; Pesenti E; Rusconi L; Saccardo MB; Vanotti E; Perrone E; Orsini P J Med Chem; 2016 Apr; 59(7):3392-408. PubMed ID: 27003761 [TBL] [Abstract][Full Text] [Related]
28. Tropomyosin receptor kinase inhibitors in the management of sarcomas. Wilding CP; Loong HH; Huang PH; Jones RL Curr Opin Oncol; 2020 Jul; 32(4):307-313. PubMed ID: 32541318 [TBL] [Abstract][Full Text] [Related]
30. Expression of trkA, trkB, and trkC in injured and regenerating retinal ganglion cells of adult rats. Cui Q; Tang LS; Hu B; So KF; Yip HK Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1954-64. PubMed ID: 12037005 [TBL] [Abstract][Full Text] [Related]
31. Pulmonary distribution, regulation, and functional role of Trk receptors in a murine model of asthma. Nassenstein C; Dawbarn D; Pollock K; Allen SJ; Erpenbeck VJ; Spies E; Krug N; Braun A J Allergy Clin Immunol; 2006 Sep; 118(3):597-605. PubMed ID: 16950277 [TBL] [Abstract][Full Text] [Related]
33. Targeting tropomyosin receptor kinase for cancer therapy. Miao Q; Ma K; Chen D; Wu X; Jiang S Eur J Med Chem; 2019 Aug; 175():129-148. PubMed ID: 31077998 [TBL] [Abstract][Full Text] [Related]
34. Identification and structural analysis of a selective tropomyosin receptor kinase C (TRKC) inhibitor. Wang Z; Ren J; Jia K; Zhao Y; Liang L; Cheng Z; Huang F; Zhao X; Cheng J; Song S; Sheng T; Wan W; Shu Q; Wu D; Zhang J; Lu T; Chen Y; Ran T; Lu S Eur J Med Chem; 2022 Nov; 241():114601. PubMed ID: 35872544 [TBL] [Abstract][Full Text] [Related]
35. GM1 ganglioside induces phosphorylation and activation of Trk and Erk in brain. Duchemin AM; Ren Q; Mo L; Neff NH; Hadjiconstantinou M J Neurochem; 2002 May; 81(4):696-707. PubMed ID: 12065629 [TBL] [Abstract][Full Text] [Related]
36. TRK inhibitors in TRK fusion-positive cancers. Drilon A Ann Oncol; 2019 Nov; 30 Suppl 8():viii23-viii30. PubMed ID: 32223935 [TBL] [Abstract][Full Text] [Related]
37. Design and synthesis of a fluorinated quinazoline-based type-II Trk inhibitor as a scaffold for PET radiotracer development. Bernard-Gauthier V; Mahringer A; Vesnaver M; Fricker G; Schirrmacher R Bioorg Med Chem Lett; 2017 Jun; 27(12):2771-2775. PubMed ID: 28476569 [TBL] [Abstract][Full Text] [Related]
38. Trk receptor expression and inhibition in neuroblastomas. Brodeur GM; Minturn JE; Ho R; Simpson AM; Iyer R; Varela CR; Light JE; Kolla V; Evans AE Clin Cancer Res; 2009 May; 15(10):3244-50. PubMed ID: 19417027 [TBL] [Abstract][Full Text] [Related]
39. Entrectinib: a potent new TRK, ROS1, and ALK inhibitor. Rolfo C; Ruiz R; Giovannetti E; Gil-Bazo I; Russo A; Passiglia F; Giallombardo M; Peeters M; Raez L Expert Opin Investig Drugs; 2015; 24(11):1493-500. PubMed ID: 26457764 [TBL] [Abstract][Full Text] [Related]